Over half of new cancer drugs ‘show no benefits’ for survival or wellbeing | Business | The Guardian https://t.co/8PqdxSUl1q
5:20am October 6th 2017 via Hootsuite
RT @harrymccracken: My colleague @thesullivan on how Google’s hardware launch acknowledged Apple on multiple fronts. https://t.co/fa5tQAjcdz
10:50pm October 5th 2017 via Hootsuite
Study: DC-area ranks 10th in venture investment - Technical.ly DC https://t.co/YtrKMJCWZY
8:45pm October 5th 2017 via Hootsuite
Karius RT @vbarsan: Amazing work in infectious disease hypothesis-free diagnostics https://t.co/3gjtvFyMnT
8:05pm October 5th 2017 via Hootsuite
LinkedIn Is Testing A New Super-Selective Recruiting Tool | Fast Company https://t.co/eTVivYHCjS
7:35pm October 5th 2017 via Hootsuite
($) RT @360DxNews: Changes in CE-IVD regulations have wide implications. Read on to find out what they are https://t.co/cDivUoEdnz
6:55pm October 5th 2017 via Hootsuite
RT @pewjournalism: Podcast audiences continued growing the last year: 40% have ever listened, 24% have listened in the past month https://t…
6:42pm October 5th 2017 via Hootsuite
RT @dalcantonJD: To have a Nobel winner openly advertise being dyslexic is a very big deal. https://t.co/NTkZiK5XUZ
5:55pm October 5th 2017 via Hootsuite
DTC genomics now on Amazon RT @insitome: Neanderthal, on Amazon Prime https://t.co/V2bRvLRvcR
4:50pm October 5th 2017 via Hootsuite
Strata Oncology, UCSF Partner to Offer $25M in Free Tumor Sequencing | Xconomy https://t.co/X2plB4KNXl
3:15pm October 5th 2017 via Hootsuite
Creative Minds: Giving Bacteria Needles to Fight Intestinal Disease | NIH Director's Blog https://t.co/zwFhd5GIeQ
2:10pm October 5th 2017 via Hootsuite
Omics! Omics!: PacBio's Frankenpatent on Error Correction https://t.co/NjWSkbFohQ
1:05pm October 5th 2017 via Hootsuite
Lessons learned on the trail of the SBIR Road Tour | Larta Blog https://t.co/hvOqoXjg0K
12:30pm October 5th 2017 via Hootsuite
Another Nobel Prize for the Fruit Fly - The New York Times https://t.co/8rwiOT7kWW
11:45am October 5th 2017 via Hootsuite
@statesdj @markgerstein @joe_pickrell @manoliskellis @carlzimmer It was Sheila Sutti (Genetic Counselor w/Brigham a… https://t.co/F1EW0Z5kM7
11:21am October 5th 2017 via Hootsuite in reply to statesdj
@laxvid Thank you Lax for introducing yourself - great to meet In Real Life! All the best - Dale
11:20am October 5th 2017 via Hootsuite in reply to laxvid
@ztfra Hi Zivana, yes it was great to meet you In Real Life too! Look forward to next week's AACR-FDA meeting too. Dale
11:19am October 5th 2017 via Hootsuite in reply to ztfra
IBM lobbying blitz seeks to shield Watson supercomputer from regulation | StatNews https://t.co/Q0blFbPxCG
10:35am October 5th 2017 via Hootsuite
After Blowing The Whistle On Theranos, Tyler Shultz Is Going Back Into Medical Testing | Forbes https://t.co/wYUDEsePs7
9:10am October 5th 2017 via Hootsuite
Inova Health System unveils new consumer genome sequencing offering via Veritas - Washington Business Journal https://t.co/NoaNWVQ9PS
8:10am October 5th 2017 via Hootsuite
Personal Genetic Testing Is Here. Do We Need It? | NYT https://t.co/pxy1lMiX07
6:58am October 5th 2017 via Hootsuite
The World’s 1st Molecular Robot Has Just Been Created by UK Scientists | Big Think https://t.co/vIaX2VmOFK
10:15pm October 4th 2017 via Hootsuite
Google and Facebook Have Failed Us - The Atlantic https://t.co/pZuB66Kvmj
8:45pm October 4th 2017 via Hootsuite
Your Birth Month Can Determine What Diseases You’ll Likely Develop | Big Think https://t.co/5ByIkvXybq
7:45pm October 4th 2017 via Hootsuite
Google and Facebook Have Failed Us - The Atlantic https://t.co/NTocCBEcC1
5:20pm October 4th 2017 via Hootsuite
Great to meet many at #genomicsfest - thank you to all who came up to say 'hi'!
4:15pm October 4th 2017 via Hootsuite
Crompton: Still need more ways to target cancer, more Rx. #genomicsfest
3:57pm October 4th 2017 via Hootsuite
Chevillet: Will see key applications - this tumor, this mutation, this Rx. EGFR resistance has been approved #genomicsfest
3:56pm October 4th 2017 via Hootsuite
Thorner: 5y? Reddi: Being able to draw correlates, from dx or prognostic perspective, where non-invasive tests become norm #genomicsfest
3:55pm October 4th 2017 via Hootsuite
Q: Anyone working to maximize pts' ctDNA content? Chevillet: One study - vigorous exercise, found muscle markers increase #genomicsfest
3:52pm October 4th 2017 via Hootsuite
Crompton: Easier to get a blood smpl; lots of pts are going to go ahead and buy it. Pts want their physicians to get all info #genomicsfest
3:51pm October 4th 2017 via Hootsuite
Reddi: Liquid biopsy isn't reimbursed yet, too new. What about VUS's? What does it mean? Solid tumor can't extrapolate to LB #genomicsfest
3:50pm October 4th 2017 via Hootsuite
Q: Guardant360 is 73; FMI is 62 genes; how will panels be adopted? Reddi: It is driven by reimb. <50 genes reimb much higher #genomicsfes
3:49pm October 4th 2017 via Hootsuite
Crompton: Tissue of origin - could be coupled with CTCs and IHC; perhaps looking at breakpoints and open chromatin for origin #genomicsfest
3:47pm October 4th 2017 via Hootsuite
Crompton: Rare subclonal TK can become dom. at time of relapse. Only way to know is more ctDNA studies. Relapse not looked at #genomicsfest
3:46pm October 4th 2017 via Hootsuite
Crompton: Answer to that is unknowable. Hint from leukemia: bone marrow from pediatric smpls - see subclonal TK events #genomicsfest
3:45pm October 4th 2017 via Hootsuite
Thorner: What about MAF that's low? Reddi: What does 0.2% mean to a pt? Heterogeneity, thus their LOD set at 1% #genomicsfest
3:44pm October 4th 2017 via Hootsuite
Reddi: Narrowed down to a handful (14) genes. What are most common cancers, most common variants. Also actionability #genomicsfest
3:43pm October 4th 2017 via Hootsuite
Q: Det cancer type? What genes, types of muts? Reddi: Looked at 2y of gene-panel results; checked against literature #genomicsfest
3:42pm October 4th 2017 via Hootsuite
Crompton: Li-Fraumeni, is 60% risk, could use liquid biopsy for freq monitoring. Problem to know what to look for, potential #genomicsfest
3:40pm October 4th 2017 via Hootsuite
Q: Liquid biopsies used proactively (screening)? Crompton: No data at all - 'very excited about it'. Pts with predisposition #genomicsfest
Reddi: QIAGEN putting resources into preanalytical variables. What is the best method as 'truth'. #genomicsfest
3:39pm October 4th 2017 via Hootsuite
Chevillet: Raises a good point - where skin cells are accidently collected in a blood draw, where epithelial CTC markers used #genomicsfest
3:38pm October 4th 2017 via Hootsuite
Thorner: Standardization of collection? Reddi: Starting-point can all be arguable; tumor cellularity in FFPE? #genomicsfest
3:36pm October 4th 2017 via Hootsuite
Crompton: Can imagine the day where resistance is actively monitored, managed like HIV. #genomicsfest
3:35pm October 4th 2017 via Hootsuite
Q: Where is the most interesting dev? Crompton: For ctDNA, the clinical prognostic outcome. #genomicsfest
3:34pm October 4th 2017 via Hootsuite
Chevillet: Unk where the most useful biomarker will be - in exosomes, in CTCs, in ctDNA. 'We have to show it.' #genomicsfest
3:32pm October 4th 2017 via Hootsuite
Chevillet: But CTC selection is a problem. MicroRNAs thought to be encapsulated and then it wasn't true. #genomicsfest
Crompton: How to control for CTCs in ctDNA samples? At 0.1%, it all matters. Chevillet: Ways to select for / against CTCs #genomicsfest
3:30pm October 4th 2017 via Hootsuite
Reddi: Not easy to transfer NIPT over to cancer; many more considerations. #genomicsfest
3:29pm October 4th 2017 via Hootsuite
